In the morning of Jun.9, international journalists from Vietnam Sai Gon Giai Phong (SGGP), Vietnam Television Corporation (VTC), Health Life Magazine (Vietnam), Televisi Republik Indonesia (TVRI), International Daily News (Indonesia), Jawa Pos, Kompas and SCTV as well as medical expert representatives gathered in St. Stamford Modern Cancer Hospital Guangzhou for the Media Interview arranged before the 17th National Conference of Radioactive Seed Brachytherapy.

As co-organizer of the academic conference and the only Sino-Singapore joint venture international medical institution, St. Stamford Modern Cancer Hospital Guangzhou organized the media interview. During the meeting, Tu Xiaoming, General Manager of St. Stamford Modern Cancer Hospital Guangzhou, introduced the main procedure and content of this conference and the purpose of this interview to the journalists and medical expert representatives.

According to Tu Xiaoming, the influence of annual National Conference of Radioactive Seed Brachytherapy is expanding on the whole in radiation filed. “This conference will continue to adhere to the principles ----focus on the frontier technology of disciplines and strengthen domestic and international academic exchanges. The main goal of this conference is to share the “Dose, Technology and Quality" of radioactive seed brachytherapy and discuss how to put the new concept, technology and standard of brachytherapy into practice in clinical work. We invite all of you here today, hoping to put the core principles of The Belt the Road Initiative, which were put forward by Chinese President Xi Jinping, into practical application and to discuss how to jointly build medical new platforms through interact consultation on significant issues and share the medical achievements together. Through mutual cooperation and exchange, information sharing and resource integration, etc., we together devote to benefiting cancer patients all over the world with rapidly changed and advanced medical technologies.”

To enhance the understanding of minimally invasive therapy, St. Stamford Modern Cancer Hospital Guangzhou gathered visitors to watch the operation video of interventional therapy and 3D printing template assisted seed implantation which was recorded in advance. Dr. Cha, director of Interventional department and Dr. Bai, leading expert of Minimally Invasive Operation Room respectively gave a detailed explanation of the operation. Additionally, Wang Huaizong, director of St. Stamford Modern Cancer Hospital Guangzhou and the Multidisciplinary Team (MDT) were on scene to answer the relative questions on medical quality management and medical service as well as minimally invasive integrated treatments on cancer, etc..

As the only organizer of the 17th National Conference of Radioactive Seed Brachytherapy, the industrial stature of St. Stamford Modern Cancer Hospital Guangzhou in Chinese Cancer medical field has been further improved and recognized, which will lay a solid foundation for the future development of MCHG in cancer treatment. It’s known that MCHG intends to develop into a Chinese chain cancer specialized medical institution in the next step, to benefit more cancer patients and fulfill their global health industry dream.

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.